A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
PHASE3CompletedINTERVENTIONAL
Enrollment
232
Participants
Timeline
Start Date
January 31, 2002
Study Completion Date
July 31, 2004
Conditions
Disruptive Behavior Disorder
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00236470 - A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders | Biotech Hunter | Biotech Hunter